Gland Consolidated December 2022 Net Sales at Rs 938.29 crore, down 11.76% Y-o-Y
January 23, 2023 / 22:51 IST
Reported Consolidated quarterly numbers for Gland Pharma are:Net Sales at Rs 938.29 crore in December 2022 down 11.76% from Rs. 1,063.33 crore in December 2021.
Quarterly Net Profit at Rs. 231.95 crore in December 2022 down 15.05% from Rs. 273.03 crore in December 2021.
EBITDA stands at Rs. 351.08 crore in December 2022 down 11.02% from Rs. 394.58 crore in December 2021.
Gland EPS has decreased to Rs. 14.08 in December 2022 from Rs. 16.62 in December 2021.
| Gland shares closed at 1,386.65 on January 20, 2023 (NSE) and has given -37.75% returns over the last 6 months and -58.03% over the last 12 months. |
| Gland Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'22 | Sep'22 | Dec'21 | | Net Sales/Income from operations | 938.29 | 1,044.40 | 1,063.33 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 938.29 | 1,044.40 | 1,063.33 | | EXPENDITURE | | Consumption of Raw Materials | 433.20 | 504.37 | 464.58 | | Purchase of Traded Goods | 3.90 | 3.79 | 4.72 | | Increase/Decrease in Stocks | -10.03 | 11.31 | 34.12 | | Power & Fuel | -- | -- | -- | | Employees Cost | 101.14 | 101.30 | 81.43 | | Depreciation | 37.61 | 36.67 | 27.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 120.50 | 126.80 | 129.56 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 251.96 | 260.18 | 321.08 | | Other Income | 61.51 | 65.62 | 45.67 | | P/L Before Int., Excpt. Items & Tax | 313.47 | 325.80 | 366.75 | | Interest | 2.62 | 1.72 | 1.18 | | P/L Before Exceptional Items & Tax | 310.85 | 324.08 | 365.56 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 310.85 | 324.08 | 365.56 | | Tax | 78.90 | 82.84 | 92.53 | | P/L After Tax from Ordinary Activities | 231.95 | 241.24 | 273.03 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 231.95 | 241.24 | 273.03 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 231.95 | 241.24 | 273.03 | | Equity Share Capital | 16.47 | 16.47 | 16.43 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 14.08 | 14.65 | 16.62 | | Diluted EPS | 14.08 | 14.65 | 16.62 | | EPS After Extra Ordinary | | Basic EPS | 14.08 | 14.65 | 16.62 | | Diluted EPS | 14.08 | 14.65 | 16.62 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
